Reducing blood cancer risks
Study finds diabetes drug metformin may inhibit the expansion of specific mutant stem cells
DTPX Therapeutics and Azane Therapeutics are the top teams at the Building a Biotech Venture Pitch Competition
Research grants awarded to products that could impact cancer and rare genetic diseases.
Three regenerative medicine experts join the Medicine by Design community through the New Investigators program
Three investigators join a cohort of 15 faculty members who have been supported by Medicine by Design’s New Investigators program.